Join Chief Scientist Officer Mathieu Fournier to explore the changing landscape of pharmaceutical impurities management, trends, and strategies. Thursday, February 8, 2024 2:00 - 2:45 PM
Register NowInsights into Nitrosamines and Emerging Trends:
Discover the intricacies of Nitrosamines and explore the observed trends and mitigation strategies that are shaping the industry.
Navigating Impurities Concerns: Understand the strategies employed when Non-Drug Substances of Risk Information (NDSRI) reach a level of concern and gain practical insights into addressing impurities effectively.
Future Considerations:
Look ahead to the future with upcoming ICH guidance, including Q14 for Method Development and Q2(R2) for Method Validation.
Exploring Pharma Industry Trends in Impurities Management
Join Chief Scientist Officer Mathieu Fournier to explore the changing landscape of pharmaceutical impurities management, trends, and strategies. Thursday, February 8, 2024 2:00 - 2:45 PM
Register Now